05 Sep, 2024 What do the Political Guidelines for the Next European Commission bring to the life sciences & healthcare industry? By Hester Borgers Ana-Maria Barbu-Nyström On 18 July 2024 President Von der Leyen laid down the path for the next European Commission in her Political Guidelines for the next...
16 Jan, 2024 HMA-EMA publish multi-annual AI workplan: further guidance on the use of AI in the medicines lifecycle By Hester Borgers In December 2023, the joint HMA-EMA Big Data Steering Group (BDSG) published a multi-annual (2023-2028) AI workplan to guide use of AI in...
05 Dec, 2023 AI in healthcare: the World Health Organisation’s regulatory considerations By Hester Borgers Dr. Nils Lölfing The World Health Organisation (WHO) has published regulatory considerations on artificial intelligence (AI) for healthcare in October...
14 Sep, 2023 EMA’s envisaged risk-based and human-centric approach to regulate AI By Hester Borgers Christian Lindenthal, LL.M. Dr. Nils Lölfing Bird & Bird’s international life sciences and healthcare team is at the forefront of the legal developments with regard to AI and the...
10 Aug, 2023 AI and the life sciences, navigating the complex legal landscape By Hester Borgers Christian Lindenthal, LL.M. Bird & Bird’s international life sciences and healthcare team is at the forefront of the legal developments with regard to AI and the...
22 May, 2023 AI as a Medical Device By Sophie Vo To add to all the chatter about AI, let’s talk about AI as a medical device. Last month, the Medicines & Healthcare products Regulatory...
04 May, 2023 What the replication crisis means for AI and drug discovery By Phillipus Putter Back in May 2016, the scientific publication Nature surveyed over 1,500 researchers to find out how reproducible their work was. This...
25 May, 2022 Artificial Intelligence Systems for Medical Diagnosis By Mauro Turrini The Italian Ministry of Health has published a document on its website entitled “Artificial Intelligence Systems as a Diagnostic Support...